PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

Catholic University of the S.Heart, Roma

Cliniques Universitaires Saint-Luc, Brussels

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven

Medizinische Universitaet Innsbruck, Universitaetsklinik fuer Dermatologie, Venerologie und Allergologie, Innsbruck

LKH - Universitaetsklinikum Graz, Graz

University Hospital Zurich Usz, Zurich

New York University School Of Medicine, Kaplan Comprehensive Cancer Center, New York

Mount Sinai Hospital, New York

Memorial Sloan Kettering Cancer Center, New York

National and Kapodistrian University of Athens - School of Health Sciences, Athens

Andreas Sygros Hosptial-University of Athen, Athens

Penn State Hershey Medical Center, Hershey

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

CHU de Dijon - Hopital du Bocage, Dijon

Elbekliniken Buxtehude, Buxtehude

University of Kiel, Kiel

Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia, Brescia

Hospital Universitario de Torrejon, Madrid

Clinical Research Center of the Carolinas, Charleston

Hannover Medical School, Hanover

Institut Claudius Regaud, Toulouse

Centre Hospitalier Universitaire de Bordeaux - Groupe Hospitalier Saint-André - Hôpital Saint-André, Bordeaux

Mount Sinai Comprehensive Cancer Center, Miami

H Lee Moffitt Cancer Center and Research Institute, Tampa

Centre Hospitalier Universitaire de Grenoble, La Tronche

Policlinico S.Orsola-Malpighi U.O. Dermatologia - University of Bologna, Bologna

Norton Cancer Institute, Louisville

Hospital Universitario Virgen Macarena, Seville

James Cancer Hospital and Solove Research Institute, Columbus

CHU Hotel Dieu, Nantes

University General Hospital of Ioannina - Dermatology and Venereology Department, Ioannina

Universitaetsklinik Essen, Essen

U.O.Dermatologia Azienda Sanitaria Firenze Universita' Firenze, Florence

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz

Hopital Huriez - CHRU de Lille, Lille

University Hospital Frankfurt, Frankfurt

Northwestern Medical Faculty Foundation, Chicago

Washington University School of Medicine, St Louis

University L'Aquila, L’Aquila

Centre Leon-Berard (CLB), Lyon

NCT Dermatoonkologie, Heidelberg

Centre Hospitalier Lyon-Sud -Hospices Civils de Lyon Groupement Hospitalier Sud, Pierre-Bénite

University Hospital Tubingen, Tübingen

Hopital Saint Louis, Paris

Centre Hospitalier Universitaire de Rouen-Hopital Charles Nicolle, Rouen

University of Texas MD Anderson Cancer Center, Houston

University of Colorado Hospital, Anschutz Outpatient Pavilion, Denver

U.O.S.C Di Oncologia Medica E Terapie Innovative, Napoli

Huntsman Cancer Institute, Salt Lake City

The University of Arizona Cancer Centre at Dignity Health, Phoenix

Mayo Clinic Arizona - Mayo Clinic Hospital, Phoenix

UC San Diego Moores Cancer Center, La Jolla

Hopital Ambroise Pare, Boulogne-Billancourt

UCSF Helen Dillion Family Cancer Care Center, San Francisco

Institut Gustave Roussy, Villejuif

Stanford Medicine Outpatient Center - Stanford Dermatology Clinic-Stanford University School of Medicine, Redwood City

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute (DFCI), Boston

Atlantic Health System / Morristown Medical Center, Morristown

Overlook Medical Center, Summit

Cross Cancer Institute, Edmonton

Odette Cancer Center-Sunnybrook Health Sciences Centre, Toronto

University Health Network, Toronto

London Regional Cancer Program, London Hsc, Toronto

Hauttumorcentrum der Charite (HTCC)-Charite Universitatsmedizin Berlin, Berlin

University Hospital Dresden, Dresden

SRH Wald-Kliniken Gera GmbH, Gera

Klinik Fur Dermatologie Und Allergollogie, Quedlinburg

National and Kapodistrian University of Athens - School of Health Sciences - Faculty of Medicine, Athens

Catalan Institute of Oncology Badalona, Badalona

Hospital Clinic I Provincialde Barcelona, Barcelona